Hypoxia-Inducible Factor-1α in Vascular Smooth Muscle Regulates Blood Pressure Homeostasis Through a Peroxisome Proliferator-Activated Receptor-γ-Angiotensin II Receptor Type 1 Axis

被引:27
|
作者
Huang, Yan [1 ,2 ]
Di Lorenzo, Annarita [4 ]
Jiang, Weidong [1 ,2 ]
Cantalupo, Anna [4 ,5 ]
Sessa, William C. [2 ,3 ]
Giordano, Frank J. [1 ,2 ]
机构
[1] Yale Univ, Sch Med, Dept Internal Med, Sect Cardiovasc Med, New Haven, CT 06520 USA
[2] Yale Univ, Sch Med, Vasc Biol & Therapeut Program, New Haven, CT 06520 USA
[3] Yale Univ, Sch Med, Dept Pharmacol, New Haven, CT 06520 USA
[4] Cornell Univ, Weill Med Coll, Dept Pathol & Lab Med, New York, NY 10021 USA
[5] Univ Naples Federico II, Dept Pharmacol, Naples, Italy
基金
美国国家卫生研究院;
关键词
angiotensins; HIF-1; hypertension; muscle; smooth; vascular; PPAR-; CELL-PROLIFERATION; ENDOTHELIAL-CELLS; HYPERTENSION; OXYGEN; HIF-1-ALPHA; RESISTANCE; HEART; ANGIOGENESIS; HYPERTROPHY; INHIBITION;
D O I
10.1161/HYPERTENSIONAHA.111.00160
中图分类号
R6 [外科学];
学科分类号
1002 ; 100210 ;
摘要
Hypertension is a major worldwide health issue for which only a small proportion of cases have a known mechanistic pathogenesis. Of the defined causes, none have been directly linked to heightened vasoconstrictor responsiveness, despite the fact that vasomotor tone in resistance vessels is a fundamental determinant of blood pressure. Here, we reported a previously undescribed role for smooth muscle hypoxia-inducible factor-1 (HIF-1) in controlling blood pressure homeostasis. The lack of HIF-1 in smooth muscle caused hypertension in vivo and hyperresponsiveness of resistance vessels to angiotensin II stimulation ex vivo. These data correlated with an increased expression of angiotensin II receptor type I in the vasculature. Specifically, we show that HIF-1, through peroxisome proliferator-activated receptor-, reciprocally defined angiotensin II receptor type I levels in the vessel wall. Indeed, pharmacological blockade of angiotensin II receptor type I by telmisartan abolished the hypertensive phenotype in smooth muscle cell-HIF-1-KO mice. These data revealed a determinant role of a smooth muscle HIF-1/peroxisome proliferator-activated receptor-/angiotensin II receptor type I axis in controlling vasomotor responsiveness and highlighted an important pathway, the alterations of which may be critical in a variety of hypertensive-based clinical settings.
引用
收藏
页码:634 / 640
页数:7
相关论文
共 50 条
  • [21] Angiotensin type 1 receptor antagonists induce human in-vitro adipogenesis through peroxisome proliferator-activated receptor-γ activation
    Janke, Juergen
    Schupp, Michael
    Engeli, Stefan
    Gorzelniak, Kerstin
    Boschmann, Michael
    Sauma, Lilian
    Nystrom, Fredrik H.
    Jordan, Jens
    Luft, Friedrich C.
    Sharma, Arya M.
    JOURNAL OF HYPERTENSION, 2006, 24 (09) : 1809 - 1816
  • [22] Suppression of Peroxisome Proliferator-Activated Receptor-γ Activity by Angiotensin II in Vascular Smooth Muscle Involves Bcr Kinase The Fire That Drowns The Water
    Schiffrin, Ernesto L.
    Paradis, Pierre
    CIRCULATION RESEARCH, 2009, 104 (01) : 4 - 6
  • [23] Significance of peroxisome proliferator-activated receptor-γ (PPAR-γ) expression in vascular smooth muscle cells
    Lee, MK
    Min, KM
    Oh, EY
    Kim, SH
    Kim, KW
    DIABETES, 1999, 48 : A130 - A130
  • [24] Peroxisome proliferator-activated receptor-γ (PPAR-γ) expression and vascular smooth muscle cell proliferation
    Lee, MK
    Min, KM
    Lee, MS
    Kim, KW
    DIABETES MELLITUS: RECENT ADVANCES FOR THE 21ST CENTURY, 2000, 1209 : 173 - 176
  • [25] Differential regulation of hypoxia-inducible factor-1 through receptor tyrosine kinase transactivation in vascular smooth muscle cells
    Lauzier, Marie-Claude
    Page, Elisabeth L.
    Michaud, Maude D.
    Richard, Darren E.
    ENDOCRINOLOGY, 2007, 148 (08) : 4023 - 4031
  • [26] Ligands of peroxisome proliferator-activated receptor-γ increase the generation of vascular endothelial growth factor in vascular smooth muscle cells and in macrophages
    Jozkowicz, A
    Dulak, J
    Piatkowska, E
    Placha, W
    Dembinska-Kiec, A
    ACTA BIOCHIMICA POLONICA, 2000, 47 (04) : 1147 - 1157
  • [27] Peroxisome proliferator-activated receptor-γ agonists increase vascular endothelial growth factor expression in human vascular smooth muscle cells
    Yamakawa, K
    Hosoi, M
    Koyama, H
    Tanaka, S
    Fukumoto, S
    Morii, H
    Nishizawa, Y
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2000, 271 (03) : 571 - 574
  • [28] Endurance training in humans leads to fiber type-specific increases in levels of peroxisome proliferator-activated receptor-γ coactivator-1 and peroxisome proliferator-activated receptor-α in skeletal muscle
    Russell, AP
    Feilchenfeldt, J
    Schreiber, S
    Praz, M
    Crettenand, A
    Gobelet, C
    Meier, CA
    Bell, DR
    Kralli, A
    Giacobino, JP
    Dériaz, O
    DIABETES, 2003, 52 (12) : 2874 - 2881
  • [29] Transcription suppression of thromboxane receptor gene by peroxisome proliferator-activated receptor-γ via an interaction with Sp1 in vascular smooth muscle cells
    Sugawara, A
    Uruno, A
    Kudo, M
    Ikeda, Y
    Sato, K
    Taniyama, Y
    Ito, S
    Takeuchi, K
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2002, 277 (12) : 9676 - 9683
  • [30] Peroxisome proliferator-activated receptor-γ ligands inhibit nitric oxide synthesis in vascular smooth muscle cells
    Ikeda, U
    Shimpo, M
    Murakami, Y
    Shimada, K
    HYPERTENSION, 2000, 35 (06) : 1232 - 1236